Loading...
Suggested application of HER2+ breast tumor phenotype for germline TP53 variant classification within ACMG/AMP guidelines
Early-onset breast cancer is the most common malignancy in women with Li-Fraumeni syndrome, caused by germline TP53 pathogenic variants. It has repeatedly been suggested that breast tumors from TP53 carriers are more likely to be HER2+ than those of non-carriers, but this information has not been in...
Na minha lista:
| Udgivet i: | Hum Mutat |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7484289/ https://ncbi.nlm.nih.gov/pubmed/32485079 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/humu.24060 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|